Skip to main content

Advertisement

Log in

Rheumatoid arthritis

Glucocorticoid therapy and body composition

  • News & Views
  • Published:

From Nature Reviews Rheumatology

View current issue Sign up to alerts

Glucocorticoids are cost-effective drugs that exert strong anti-inflammatory and immunosuppressive effects. However, there is increasing awareness of their potential adverse effects. Although Cushingoid appearance and weight gain have been known for decades, modern measurements of body composition now enable detailed insights into glucocorticoid-induced changes in fat mass and redistribution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: The two-compartment model of body composition.

References

  1. van der Goes, M. C. et al. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann. Rheum. Dis. 69, 1015–1021 (2010).

    Article  CAS  Google Scholar 

  2. Konijn, N. P. et al. The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/kew221 (2016).

  3. Buttgereit, F., Smolen, J. S., Coogan, A. N. & Cajochen, C. Clocking in: chronobiology in rheumatoid arthritis. Nat. Rev. Rheumatol. 11, 349–356 (2015).

    Article  CAS  Google Scholar 

  4. Arvidson, N. G., Gudbjornsson, B., Larsson, A. & Hallgren, R. The timing of glucocorticoid administration in rheumatoid arthritis. Ann. Rheum. Dis. 56, 27–31 (1997).

    Article  CAS  Google Scholar 

  5. Cutolo, M. Glucocorticoids and chronotherapy in rheumatoid arthritis. RMD Open 2, e000203 (2016).

    Article  Google Scholar 

  6. Smith-Ryan, A. E. et al. Validity and reliability of a 4-compartment body composition model using dual energy X-ray absorptiometry-derived body volume. Clin. Nutr. http://dx.doi.org/10.1016/j.clnu.2016.05.006 (2016).

  7. Summers, G. D., Metsios, G. S., Stavropoulos-Kalinoglou, A. & Kitas, G. D. Rheumatoid cachexia and cardiovascular disease. Nat. Rev. Rheumatol. 6, 445–451 (2010).

    Article  Google Scholar 

  8. Walsmith, J. & Roubenoff, R. Cachexia in rheumatoid arthritis. Int. J. Cardiol. 85, 89–99 (2002).

    Article  Google Scholar 

  9. Arshad, A., Rashid, R. & Benjamin, K. The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism. Mod. Rheumatol. 17, 470–475 (2007).

    Article  Google Scholar 

  10. Elkan, A. C., Hakansson, N., Frostegard, J., Cederholm, T. & Hafstrom, I. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res. Ther. 11, R37 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frank Buttgereit.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buttgereit, F., Burmester, G. Glucocorticoid therapy and body composition. Nat Rev Rheumatol 12, 444–445 (2016). https://doi.org/10.1038/nrrheum.2016.114

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2016.114

  • Springer Nature Limited

Navigation